4//SEC Filing
Klein Matthew B. 4
Accession 0001415889-25-021130
CIK 0001070081other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 8:30 PM ET
Size
7.6 KB
Accession
0001415889-25-021130
Insider Transaction Report
Form 4
Klein Matthew B.
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Common Stock
2025-08-01+75,000→ 348,506 total - Sale
Common Stock
2025-08-05$51.74/sh−10,739$555,636→ 337,767 total
Footnotes (3)
- [F1]Represents the number of shares of the Issuer's common stock underlying restricted stock units ("RSUs") earned upon the vesting of performance-based restricted stock units ("PSUs") granted in December 2023. On August 1, 2025, the Issuer's board of directors certified the Issuer's achievement of a pre-established regulatory milestone set forth in the PSUs, which resulted in the reported RSUs being earned. Each earned RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting. The earned RSUs immediately vested as to 25,000 shares on August 1, 2025 in connection with being earned and are scheduled to vest with respect to the remaining 50,000 shares in equal annual installments on August 1, 2026 and August 1, 2027.
- [F2]Includes 272 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2025.
- [F3]Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the RSU grant to satisfy tax withholding obligations in connection with the vesting of the earned RSUs with respect to 25,000 shares on August 1, 2025.
Documents
Issuer
PTC THERAPEUTICS, INC.
CIK 0001070081
Entity typeother
Related Parties
1- filerCIK 0001808968
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 8:30 PM ET
- Size
- 7.6 KB